references
ADVOCACY, COMMUNICATIONS & FUNDRAISING
Maintaining balanced and diversified funding is essential to DNDi’s vision and independence
To develop its activities and meet its objectives, DNDi seeks diversified sources of funding from public and private sources, which include financial contributions from governments, public institutions, private individuals, foundations, founding partners, and innovative funding mechanisms. The diversification of donors increased in 2015 with three new donors. DNDi welcomed WHO-TDR, the Ministry of Health of Brazil, and Kalacore, all public sources of financing, and one from an endemic country. Concerted efforts were made to ensure that no one donor contributes more than around 25% towards DNDi’s business plan and that at maturity, half of DNDi’s budget is covered by public funds and half by private funds. In 2014, public funding (projected to 2019) was at 51%, with private support at 49%. In 2015, with secured funds until 2020, the split remains balanced with public funding at 54% and 46% for private support. This is mainly due to the fact that most (EUR 30.2 M, 98%) of the new funding granted in 2015 for the period 2015-2020 are contributions from public institutions, including the UK (DFID), WHO-TDR, France (AFD), Japan (GHIT), Brazil (BNDS), Germany (KfW), and the Netherlands (DGIS).
Private Contributions
EUR 181.5 M
Public Institutional Contributions
EUR 213.2 M
EUR 85.6 M UK (DFID): 22% EUR 33 M The Netherlands (DGIS): 8% EUR 16.3 M France (AFD): 4% EUR 102.4 M Bill & Melinda
Gates Foundation: 26%
46% 54%
EUR 15.5 M UNITAID: 4% EUR 12.5 M Switzerland
(SDC and Canton of Geneva): 3%
EUR 12 M Spain (AECID): 3% EUR 10.7 M USA Government NIH/ NIAID/USAID: 3% EUR 10.1 M Germany (BMBF through KfW and GtZ): 3% EUR 6.7 M Japan (GHIT): 1.5% EUR 6.4 M others: 1.5% EUR 4.4 M European Union (FP5, FP6, FP7, EDCTP): 1%
EUR 65.9 M Médecins
Sans Frontières: 17%
EUR 13.2 M Various private
donors: Wellcome Trust, Medicor, others: 3%
A successful shift toward unrestricted funding
FOUR MAIN FUNDERS BETWEEN 20032020 CUMULATE 73% OF THE FUNDS COMMITTED TO DNDi
Over the last five years, DNDi managed to maintain a balance between restricted and unrestricted grants. While the ratio is relatively balanced, this requires substantial effort. Unrestricted funding has been part of DNDi’s success to date as it allows the organization to respond quickly to research opportunities and also terminate projects that do not meet targeted goals set forth in the business plan. In 2015, DNDi continued to receive significant portfolio funding (EUR 21.2 M, 69%) from various donors including the Netherlands (DGIS), France (AFD), WHO-TDR, and Brazil (BNDS). This allows a certain degree of risk mitigation within restricted grants, as it supports three diseases and various projects within each disease. Portfolio grants accounted for 18% of total income in 2011, 22% in 2012, 29% in 2013, 33% in 2014, and 37% in 2015. CUMULATED 2003-2020: EUR 394.7 MILLION
Médecins Sans Frontières Bill & Melinda Gates Foundation The Netherlands (DGIS) UK (DFID) Other Public Institutional Contributions Other private donors
Portfolio 37% funding
26%
73%
17%
3% 24% 22% 8%
Unrestricted
44%
Restricted
56%
19%
Strictly restricted
DNDi Annual Report 2015 › 67
2015 KEY FINANCIAL PERFORMANCE INDICATORS
